Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment

Wednesday, May 25, 2011 General News
Email Print This Page Comment bookmark
Font : A-A+

CEN-209 shows potential to enable successful treatment of tumors that are resistant to standard treatments like radiotherapy and chemotherapy

FOR INFORMATION CONTACT:

Centella/Varian Medical Systems

Auckland UniServices, Ltd

Meryl Ginsberg, 650-424-6444

Josie Heap, +64 9 923 4216

meryl.ginsberg@varian.com

j.heap@auckland.ac.nz

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store